Details for New Drug Application (NDA): 088207
✉ Email this page to a colleague
NDA 088207 describes GERIMAL, which is a drug marketed by Watson Labs and is included in three NDAs. Additional details are available on the GERIMAL profile page.
The generic ingredient in GERIMAL is ergoloid mesylates. There are four drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the ergoloid mesylates profile page.
The generic ingredient in GERIMAL is ergoloid mesylates. There are four drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the ergoloid mesylates profile page.
Summary for 088207
| Tradename: | GERIMAL |
| Applicant: | Watson Labs |
| Ingredient: | ergoloid mesylates |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 088207
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 1MG | ||||
| Approval Date: | Mar 22, 1984 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
